Turret Capital Launches Sable, a Biotech-Driven Beauty Brand Advancing Body Contouring and Aesthetic Longevity
PR Newswire —
Sable, a portfolio company of Turret Capital, announces its pre-seed funding and launch NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Turret Capital, a leading healthcare-focused venture firm, today announced the launch of Sable, a pioneering biotech driven consumer beauty company. Backed by...